First, a disclaimer: No market map is fully exhaustive.

We focused our efforts on the companies deploying AI agents in the ambulatory or outpatient setting. These companies are generally also post-series A, as there has been an explosion of pre-seed and seed activity in the space. We also excluded vendors whose primary business model is selling into healthcare systems. Submissions came from a cross section of our network, inclusive of venture capital investors, operators, and founders (see the full list that contributed directly underneath the map).

To be fully transparent, we struggled a bit in the scribe category because, in some cases, the agents involve a roadmapping exercise, while others are live.

If your company fits the criteria and should be on the list, reach out to us before our next update!

_Second Opinion x Confido Mini Market Map .png

Second Opinion x Confido Market Map

366.05 KBPNG File

Reserve Your Spot for Upcoming Webinars!

Webinar Topic

Panelists’

Timing

Registration

Privacy AI and the future of HIPAA with the former founding director of ONC

Jodi Daniel, Christina Farr

June 3rd, 2026
At 12:00 PM (ET)

Not everyone can access the Top 1% of physicians. Will AI change that?

Daniel Stein
Christina Farr

June 18th, 2026
At 1:00 PM (ET)

Want to support Second Opinion?

logo

Want more? Second Opinion Premium goes further.

Second Opinion Premium membership gives you even more depth, with exclusive reporting, member-only insights, and practical tools you can put to work.

Upgrade to Premium

Premium membership unlocks:

  • Exclusive deep dives and strategic perspectives
  • Market maps, guides, and frameworks
  • Members-only webinars and events
  • Exclusive reports and evidence-backed analysis

Reply

Avatar

or to participate

Keep Reading